Internal Medicine, Hematology & Oncology · Chicago, IL
NPI
1336371590
Since 2009
Specialty
Internal Medicine, Hematology & Oncology
Code 207RH0003X
Group practices
3
Medicare group memberships
Hospitals
5
Hospital affiliations
1740 W Taylor St
Chicago, IL, 60612
Phone (312) 996-1581
Groups this clinician bills Medicare through
Medicare paid, 2024
$583K
22,997 services
Medicare patients, 2024
235
Average age 71
Drug cost, 2024
$1.7M
957 prescriptions
Company payments, 2025
$24.08
From 2 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Jonathan Moreira was code J2919 (injection, methylprednisolone sodium succinate, 5 mg), 2,300 times for 18 patients. In total Jonathan Moreira billed 22,997 services in 95 codes, and Medicare paid $583K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2018-03-17.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| J2919 Injection, methylprednisolone sodium succinate, 5 mg | Office | 2,300 | 18 | $0.24 | $546 |
| J9144 Injection, daratumumab, 10 mg and hyaluronidase-fihj | Office | 1,980 | 11 | $40.25 | $80K |
| J1569 Injection, immune globulin, (gammagard liquid), non-lyophilized, (e.g., liquid), 500 mg | Office | 1,220 | 20 | $37.06 | $45K |
| 99232 Hospital E&M - Subsequent | Facility | 348 | 65 | $64.58 | $22K |
| G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | Office | 194 | 64 | $12.99 | $2,519 |
| 99214 Office E&M - Established | Office | 183 | 69 | $95.18 | $17K |
| J1100 Injection, dexamethasone sodium phosphate, 1 mg | Office | 180 | 15 | $0.09 | $15.82 |
| 99215 Office E&M - Established | Office | 166 | 36 | $144.07 | $24K |
| J2469 Injection, palonosetron hcl, 25 mcg | Office | 150 | 14 | $0.52 | $78.11 |
| 99233 Hospital E&M - Subsequent | Facility | 78 | 31 | $96.38 | $7,518 |
| 96413 Chemotherapy Administration | Office | 55 | 48 | $105.29 | $5,791 |
| 96375 Injection Administration | Office | 54 | 32 | $12.47 | $674 |
| 96366 Intravenous Infusion, Hydration | Office | 35 | 22 | $16.48 | $577 |
| 96365 Intravenous Infusion, Hydration | Office | 30 | 29 | $51.14 | $1,534 |
| 99239 Hospital Discharge Management | Facility | 27 | 27 | $93.37 | $2,521 |
By year: 2022 $769K for 27,044 services; 2023 $705K for 28,237 services; 2024 $583K for 22,997 services.
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 36415 Venipuncture Blood Collection | 13 | 11 | $8.65 | $112 |
Medicare prescription drug claims, 2024
In 2024, the drug Jonathan Moreira prescribed most often to Medicare patients was Valacyclovir (Valacyclovir Hcl), with 93 prescriptions and refills. In total Jonathan Moreira wrote 957 Medicare prescriptions that cost $1.7M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Valacyclovir Valacyclovir Hcl | 93 | 130 | 21 | $3,555 |
| Ursodiol Generic | 61 | 76 | Under 11 | $2,827 |
| Jakafi Ruxolitinib Phosphate | 55 | 57 | 11 | $847K |
| Prednisone Generic | 53 | 66 | 11 | $378 |
| Magnesium Sulfate Generic | 48 | 48 | Under 11 | $1,208 |
| Pantoprazole Sodium Generic | 44 | 88 | 11 | $470 |
| Sulfamethoxazole-Trimethoprim Sulfamethoxazole/Trimethoprim | 41 | 63 | 11 | $155 |
| Gabapentin Generic | 26 | 36 | Under 11 | $207 |
| Ondansetron Odt Ondansetron | 25 | 25 | Under 11 | $250 |
| Tacrolimus Generic | 25 | 26 | Under 11 | $1,201 |
| Acyclovir Generic | 25 | 39 | Under 11 | $230 |
| Mirtazapine Generic | 25 | 27 | Under 11 | $211 |
| Posaconazole Generic | 23 | 23 | Under 11 | $35K |
| Amlodipine Besylate Generic | 21 | 47 | Under 11 | $154 |
| Eliquis Apixaban | 20 | 20 | Under 11 | $12K |
Brand drugs: - claims; generic drugs: 751 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Jonathan Moreira $24.08 ($24.08 in general payments such as food, travel and fees) from 2 companies. The largest payer was Astellas Pharma US Inc with $24.08.
| Company | Payments | Amount |
|---|---|---|
| Astellas Pharma US Inc 4503.T | 1 | $24.08 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.